Key Documents

View All Documentation

M8168

4-Methylumbelliferyl phosphate disodium salt

Name: 4-Methylumbelliferyl phosphate disodium salt
Brand: SIGMA

phosphatase substrate, ≥98% (TLC), powder

Synonym(s):

4-MUP, Disodium 4-methylumbelliferyl phosphate

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):

C₁₀H₇Na₂O₆P

CAS Number:

22919-26-2

Molecular Weight:

300.11

NACRES:

NA.32

PubChem Substance ID:

24897230

UNSPSC Code:

12352204

EC Number:

245-325-0

MDL number:

MFCD00037614

Technical Service

Need help? Our team of experienced scientists is here for you.

Let Us Assist

Product Name

4-Methylumbelliferyl phosphate disodium salt, phosphatase substrate

Quality Level

300

assay

≥98% (TLC)

form

powder

solubility

water: 50 mg/mL, clear, colorless

fluorescence

λ_ex 319 nm; λ_em 384 nm (pH 9.0), λ_ex 360 nm; λ_em 449 nm (Reaction product)

storage temp.

−20°C

SMILES string

[Na+].[Na+].CC1=CC(=O)Oc2cc(OP([O-])([O-])=O)ccc12

InChI

1S/C10H9O6P.2Na/c1-6-4-10(11)15-9-5-7(2-3-8(6)9)16-17(12,13)14;;/h2-5H,1H3,(H2,12,13,14);;/q;2*+1/p-2

InChI key

WUUDJQVNZPEPKN-UHFFFAOYSA-L

Related Categories

Phosphates

General description

Fluorogenic substrate for phosphatases.

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

0000507890

0000432629

0000375479

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial.

Rubhana Raqib et al.

BMC infectious diseases, 12, 111-111 (2012-05-12)

Treatment of shigellosis in rabbits with butyrate reduces clinical severity and counteracts the downregulation of cathelicidin (CAP-18) in the large intestinal epithelia. Here, we aimed to evaluate whether butyrate can be used as an adjunct to antibiotics in the treatment

Rapid induction of IgE responses to a worm cysteine protease during murine pre-patent schistosome infection.

Lucia A de Oliveira Fraga et al.

BMC immunology, 11, 56-56 (2010-11-17)

During the pre-patent stage of infection, juvenile Schistosoma blood flukes co-opt signals from the adaptive immune system to facilitate parasite development, but the types of responses that are induced at this early stage of infection, and the parasite antigens they

Identification of a target protein of Hydra actinoporin-like toxin-1 (HALT-1) using GST affinity purification and SILAC-based quantitative proteomics.

Ameirika et al.

Toxicon : official journal of the International Society on Toxinology, 133, 153-161 (2017-05-10)

Hydra actinoporin-like toxin-1 (HALT-1) is a 20.8 kDa pore-forming toxin isolated from Hydra magnipapillata. HALT-1 shares structural similarity with actinoporins, a family that is well known for its haemolytic and cytolytic activity. However, the precise pore-forming mechanism of HALT-1 remains an

Improved Brain Insulin/IGF Signaling and Reduced Neuroinflammation with T3D-959 in an Experimental Model of Sporadic Alzheimer's Disease.

Suzanne M de la Monte et al.

Journal of Alzheimer's disease : JAD, 55(2), 849-864 (2016-11-02)

Alzheimer's disease (AD) is associated with progressive impairments in brain insulin, insulin-like growth factor (IGF), and insulin receptor substrate (IRS) signaling through Akt pathways that regulate neuronal growth, survival, metabolism, and plasticity. The intracerebral streptozotocin (i.c. STZ) model replicates the

A novel nanoluciferase-based system to monitor Trypanosoma cruzi infection in mice by bioluminescence imaging.

Erica Silberstein et al.

PloS one, 13(4), e0195879-e0195879 (2018-04-20)

Chagas disease, caused by the intracellular protozoan Trypanosoma cruzi, affects 8-10 million people worldwide and represents a major public health challenge. There is no effective treatment or vaccine to control the disease that is characterized by a mild acute phase

View All Related Papers

Global Trade Item Number

SKU	GTIN
M8168-250MG	04061832909295
M8168-1MG	04061823207188
M8168-1G	04061834062905

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service